This NDC is on FDA's drug shortage list (posted Feb 22, 2012)

Reported reason: Demand increase for the drug

Product Information

LIDOCAINE HCL 1% VIAL is a generic product labeled by Fresenius Kabi USA, LLC, priced at $0.2441 per ML under NDC 63323020110. Its NADAC has been published 265 times since Nov 28, 2013.

FDA first approved this application before 1982. Its Orange Book therapeutic-equivalence code is AP.

LIDOCAINE HCL 1% VIAL

LIDOCAINE HYDROCHLORIDE
$0.2441per ML

Strength

10 mg/mL

NDC

63323020110

Classification

Generic

Dosage Form

INJECTION, SOLUTION

Route

INFILTRATION; PERINEURAL

Effective Date

11/18/2026

Active Ingredients

LIDOCAINE HYDROCHLORIDE

Approval Type

Generic (ANDA)

FDA Application

ANDA088586

FDA Approved

Before 1982

TE Code

AP

On Market Since

5/27/2010

Pharmacological Classes

Price Statistics

The NADAC for LIDOCAINE HCL 1% VIAL has been published 265 times since Nov 28, 2013, and over the history we have for it it has risen 88.9%. The table below summarizes its recorded NADAC range and movement.

Current price$0.2441 per ML
All-time high$0.2441 (Nov 18, 2026)
All-time low$0.1197 (Feb 18, 2026)
52-week high$0.2441
52-week low$0.1197
Median price$0.1563
Average price$0.1633
Largest weekly change+77.1% (Nov 18, 2026)
Weeks tracked265
Tracking sinceNov 28, 2013

Price History

1W

+77.1%

1M

+77.1%

3M

+77.1%

6M

+87.1%

1Y

+84.7%

3Y

+26.1%

5Y

+56.2%

All

+88.9%

Generic Alternatives

The matcher finds 4 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 78% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of LIDOCAINE HCL 1% VIAL?

The current National Average Drug Acquisition Cost (NADAC) for LIDOCAINE HCL 1% VIAL, manufactured by Fresenius Kabi USA, LLC, is $0.2441 per ML (NDC 63323020110), effective Nov 18, 2026.

How has the price of LIDOCAINE HCL 1% VIAL changed over time?

Over the history we have for it, the NADAC for LIDOCAINE HCL 1% VIAL has risen 88.9%. It has been tracked across 265 weekly CMS publications since Nov 28, 2013.

What are the highest and lowest recorded NADAC prices for LIDOCAINE HCL 1% VIAL?

Since Nov 28, 2013, the NADAC for LIDOCAINE HCL 1% VIAL has ranged from a low of $0.1197 (Feb 18, 2026) to a high of $0.2441 (Nov 18, 2026), with a median of $0.1563 per ML.

Are there cheaper alternatives to LIDOCAINE HCL 1% VIAL?

Yes. 4 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, LIDOCAINE HCL 1% VIAL, is $0.0542 per ML — about 78% below LIDOCAINE HCL 1% VIAL.

Who manufactures LIDOCAINE HCL 1% VIAL?

LIDOCAINE HCL 1% VIAL (NDC 63323020110) is labeled by Fresenius Kabi USA, LLC, and CMS classifies it as a generic product.

Is LIDOCAINE HCL 1% VIAL in shortage?

Yes — NDC 63323020110 is currently listed in FDA's drug shortage database (posted Feb 22, 2012). Reported reason: Demand increase for the drug.